IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue’s Discovery Park District. As the COVID-19 pandemic was about to break around the globe, IdentifySensors, the parent company of IdentifySensors Biologics, had approached Purdue to help it develop a nanosensor designed to detect spoilage and specific pathogens in the food supply chain. When the pandemic became apparent, the company pivoted to start working with Purdue researcher Lia Stanciu, associate head and professor of materials engineering, to develop a rapid diagnostic platform for detecting SARS-CoV-2, the virus that causes COVID-19. IdentifySensors Biologics has partnered with PRF and has opened an office in the Convergence Center for Innovation and Collaboration in Purdue’s Discovery Park District. PRF is investing $50,000 in IdentifySensors.